Regen BioPharma, Inc. Financial Ratios — RGBP Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-1,195.09	-1,913.15	-1,264.72	-924.19	-817.72	-1,702.78	2,457.79	-1,013.3	251.49	224.3	-259.67	-585.02
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	-54.47	- -	-29.24	-19.49	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	100	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	- -	- -	-1,030.87	-2,956.96	-2,282.62	-1,425.78	-687.99	-190.29	-117.28	-144.2	-290.39	-176.37	-143.11
Operating Margin (%)	- -	- -	-1,030.87	-2,956.96	-2,282.62	-1,425.78	-687.99	-190.29	-117.28	-144.2	-290.39	-176.37	-143.11
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	-1,151.41	-3,413.52	-5,308.22	-4,715.2	-2,384.71	3,104.02	-3,951.79	1,037.52	488.89	-282.49	-538.76
Profit Margin (%)	- -	- -	-1,151.41	-3,413.52	-5,308.22	-4,715.2	-2,384.71	2,483.21	-3,951.79	945.59	432.66	-282.49	-538.76
Net Income to Common Margin (%)	- -	- -	-1,151.41	-3,413.52	-5,308.22	-4,715.2	-2,384.71	2,483.21	-3,951.79	945.59	432.66	-282.49	-538.76
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Total Debt	- -	- -	- -	- -	1	1	2	3	4	1	1	1	1
ST Debt	- -	- -	- -	- -	- -	1	2	3	4	1	1	1	1
LT Debt	- -	- -	- -	- -	- -	1	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	-0.18	-0.11	-0.09	-0.28	-1	-2.84	-12.44	-17.85	-3.75	-1.1	-1.9	-3.54
Net Debt/EBITDA	0.36	-0.18	-0.09	-0.08	-0.17	-1	-2.83	-12.44	-14.22	-3.6	-0.92	-1.9	-3.33
Total Debt/EBIT	- -	-0.18	-0.11	-0.09	-0.28	-1	-2.84	-12.44	-17.85	-3.75	-1.1	-1.9	-3.54
Net Debt/EBIT	0.36	-0.18	-0.09	-0.08	-0.17	-1	-2.83	-12.44	-14.22	-3.6	-0.92	-1.9	-3.33
EBITDA to Interest Expense	- -	-319.33	-91.26	-63.7	-4.36	-0.91	-0.44	-0.22	-0.55	-1.62	-11.56	-4.11	-1.61
EBITDA-CapEx/Interest Expense	- -	-319.33	-91.26	-63.7	-4.36	-0.91	-0.44	-0.22	-0.55	-1.62	-11.56	-4.11	-1.61
EBIT to Interest Expense	- -	-319.33	-91.26	-63.7	-4.36	-0.91	-0.44	-0.22	-0.55	-1.62	-11.56	-4.11	-1.61
Interest Expense	- -	- -	- -	- -	1	2	2	1	- -	- -	- -	- -	- -
Common Equity/Total Assets	100	-1,216.62	-46.85	-188.01	-557.93	-4,372.6	-11,048.31	-5,988.83	-1,116.53	-1,446.22	-1,443.38	-3,239.54	-2,287.53
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	-32.7	-7.29	-8.55	-0.06	- -	- -	- -	-3.44	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	33.52	35.2	314.41	5.02	- -	- -	- -	42.31	- -	- -
Total Debt/Equity (%)	- -	-97.44	-229.2	-44.22	-13.19	-15.7	-19.68	-35.51	-26.57	-15.85	-14.8	-15.21	-19.07
Total Debt/Capital (%)	- -	-3,798.68	177.4	-79.29	-15.19	-18.63	-24.51	-55.07	-36.18	-18.84	-17.37	-17.94	-23.56
Total Debt/Total Assets (%)	- -	1,185.42	101.04	81.27	73.36	685.24	2,166.98	2,114.55	295.6	227.92	213.57	492.72	436.18
Net Debt to Equity	-100	-97.44	-189.46	-39.99	-8.05	-15.61	-19.61	-35.51	-21.18	-15.22	-12.42	-15.2	-17.96
Net Debt/Capital (%)	- -	-3,798.68	211.78	-66.65	-8.75	-18.5	-24.4	-55.07	-26.87	-17.95	-14.19	-17.92	-21.9
EBITDA	- -	-1	-2	-3	-3	-1	-1	- -	- -	- -	-1	- -	- -
EBITDA-CapEx	- -	-1	-2	-3	-3	-1	-1	- -	- -	- -	-1	- -	- -
Operating Income (Loss)	- -	-1	-2	-3	-3	-1	-1	- -	- -	- -	-1	- -	- -

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Cash Ratio	- -	- -	0.12	0.03	0.05	- -	- -	- -	0.05	0.01	0.02	- -	0.01
Current Ratio	- -	0.08	0.2	0.26	0.08	- -	0.01	0.01	0.07	0.04	0.02	0.03	0.04
Quick Ratio	- -	0.08	0.16	0.17	0.08	- -	0.01	0.01	0.06	0.04	0.02	0.02	0.04
CFO/Avg Current Liab	- -	-10.65	-5.21	-2.99	-0.57	-0.22	-0.05	- -	-0.1	-0.05	-0.03	-0.14	-0.06
Common Equity/Total Assets	100	-1,216.62	-46.85	-188.01	-557.93	-4,372.6	-11,048.31	-5,988.83	-1,116.53	-1,446.22	-1,443.38	-3,239.54	-2,287.53
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	-32.7	-7.29	-8.55	-0.06	- -	- -	- -	-3.44	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	33.52	35.2	314.41	5.02	- -	- -	- -	42.31	- -	- -
Total Debt/Equity (%)	- -	-97.44	-229.2	-44.22	-13.19	-15.7	-19.68	-35.51	-26.57	-15.85	-14.8	-15.21	-19.07
Total Debt/Capital (%)	- -	-3,798.68	177.4	-79.29	-15.19	-18.63	-24.51	-55.07	-36.18	-18.84	-17.37	-17.94	-23.56
Total Debt/Total Assets (%)	- -	1,185.42	101.04	81.27	73.36	685.24	2,166.98	2,114.55	295.6	227.92	213.57	492.72	436.18
CFO/Total Liabilities	- -	-532.41	-375.47	-184.52	-30.58	-16.91	-4.38	0.25	-7.69	-7.06	-3.19	-13.97	-5.85
CFO/CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	- -	-365.84	-11.12	-51.16	-33.76	-188.37	-438.9	-264.79	-35.53	-69.38	-100.8	-223.4	-141.18

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Accounts Receivable Turnover	- -	- -	- -	2.41	2.65	- -	3.09	1.26	1.08	1.01	1.86	4.99	1.58
Days Sales Outstanding	- -	- -	- -	151.48	137.7	- -	118.1	289.31	337.28	362.23	196.17	73.19	231.25
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Market Capitalization	- -	8	22	17	7	2	1	- -	133	33	6	1	1
- Cash & Cash Equivalents	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	1	1	2	3	4	1	1	1	1
Enterprise Value	- -	8	22	18	7	4	3	3	136	34	7	2	2
Total Capital	- -	- -	- -	- -	-5	-8	-9	-5	-10	-7	-4	-4	-5
Total Debt/Capital (%)	- -	-3,798.68	177.4	-79.29	-15.19	-18.63	-24.51	-55.07	-36.18	-18.84	-17.37	-17.94	-23.56
Total Debt / EV	- -	0.01	0.01	0.01	0.1	0.4	0.76	0.83	0.03	0.04	0.11	0.42	0.72
EV/Sales	- -	- -	114.55	177.14	63.57	35.72	25.8	28.45	791.55	144.4	29.44	7.92	7.02
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	2.33	3.25	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	2.33	3.25	- -	- -	- -	- -	- -
Diluted Market Cap	- -	8	17	16	7	2	2	- -	92	31	6	1	- -
Diluted Enterprise Value	- -	8	17	16	7	3	4	3	95	32	7	2	1
EV per Share	- -	121.82	143.74	95.09	37.54	14.86	3.55	1.46	23.36	5.07	0.99	0.18	0.04
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	- -	-1	-2	-3	-3	-1	-1	- -	- -	- -	-1	- -	- -
TTM Operating Income	- -	-1	-2	-3	-3	-1	-1	- -	- -	- -	-1	- -	- -
TTM Cash Flow to Firm	- -	-1	-1	-2	-1	- -	1	1	-1	- -	- -	-1	- -
TTM Free Cash Flow to Firm	- -	-1	-1	-2	-1	- -	1	1	-1	- -	- -	-1	- -

Multiples (USD)

Valuation Multiples API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Price/Free Cash Flow	- -	-11.08	-14.05	-9.56	-3.5	-1.14	-4.73	22.68	-81.16	-50.43	-36.71	-1.44	-0.83
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	8	22	18	7	4	3	3	136	34	7	2	2
Low Price	- -	7.5	0.08	49.14	13.5	7.44	0.38	- -	0.15	2.58	0.52	0.06	0.01
EV/Sales	- -	- -	114.55	177.14	63.57	35.72	25.8	28.45	791.55	144.4	29.44	7.92	7.02
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	0.15	- -	13.74	6.24	- -	- -
Price/Earnings Average	- -	-16.22	-7.03	-4.85	-1.44	-1.19	-2.21	0.15	-5.73	22.06	13.48	-6.59	-1.29
Price/Earnings High	- -	-68.39	-17.87	-8.2	-3.14	-4.12	-11.54	0.98	-36.47	75.36	37.87	-15.42	-4.98
Price/Earnings Low	- -	-0.68	- -	-2.45	-0.44	-0.32	-0.39	- -	-0.09	7.27	3.56	-0.91	-0.2
Price/Book Value	- -	-64.07	-211.09	-29.09	-1.24	-0.23	-0.06	-0.07	-9.8	-4.05	-1.24	-0.21	-0.08
Price/Book Value Average	- -	-94.99	-195.72	-30.13	-1.58	-0.73	-0.15	-0.06	-4.14	-6.5	-2.68	-0.84	-0.44
Price/Book Value High	- -	-400.43	-497.73	-50.96	-3.43	-2.52	-0.8	-0.41	-26.33	-22.21	-7.53	-1.97	-1.69
Price/Book Value Low	- -	-4	-0.11	-15.25	-0.48	-0.2	-0.03	- -	-0.06	-2.14	-0.71	-0.12	-0.07
Price/Tangible Book Value	- -	-64.07	-211.09	-29.09	-1.24	-0.23	-0.06	-0.07	-9.8	-4.05	-1.24	-0.21	-0.08
Price/Tangible Book Value Average	- -	-94.99	-195.72	-30.13	-1.58	-0.73	-0.15	-0.06	-4.14	-6.5	-2.68	-0.84	-0.44
Price/Tangible Book Value High	- -	-400.43	-497.73	-50.96	-3.43	-2.52	-0.8	-0.41	-26.33	-22.21	-7.53	-1.97	-1.69
Price/Tangible Book Value Low	- -	-4	-0.11	-15.25	-0.48	-0.2	-0.03	- -	-0.06	-2.14	-0.71	-0.12	-0.07
Price/Sales	- -	- -	87.27	159.82	60.31	17.97	20.71	3.85	536.19	129.95	26.99	4.57	1.34
Price/Sales Average	- -	- -	80.91	165.53	76.43	56.14	52.82	3.63	226.48	208.62	58.33	18.62	6.96
Price/Sales High	- -	- -	205.76	279.99	166.52	194.27	275.15	24.44	1,441.09	712.6	163.87	43.57	26.85
Price/Sales Low	- -	- -	0.05	83.76	23.14	15.09	9.41	0.01	3.52	68.7	15.4	2.56	1.06
Price/Cash Flow	- -	-11.08	-14.05	-9.56	-3.5	-1.14	-4.73	22.68	-81.16	-50.43	-36.71	-1.44	-0.83
Price/Cash Flow Average	- -	-16.43	-13.03	-9.9	-4.44	-3.56	-12.06	21.41	-34.28	-80.95	-79.35	-5.86	-4.29
Price/Cash Flow High	- -	-69.26	-33.13	-16.74	-9.67	-12.31	-62.82	144.17	-218.14	-276.53	-222.89	-13.71	-16.56
Price/Cash Flow Low	- -	-0.69	-0.01	-5.01	-1.34	-0.96	-2.15	0.08	-0.53	-26.66	-20.95	-0.81	-0.66
Price/Free Cash Flow Average	- -	-16.43	-13.03	-9.9	-4.44	-3.56	-12.06	21.41	-34.28	-80.95	-79.35	-5.86	-4.29
Price/Free Cash Flow High	- -	-69.26	-33.13	-16.74	-9.67	-12.31	-62.82	144.17	-218.14	-276.53	-222.89	-13.71	-16.56
Price/Free Cash Flow Low	- -	-0.69	-0.01	-5.01	-1.34	-0.96	-2.15	0.08	-0.53	-26.66	-20.95	-0.81	-0.66
EV/Sales Average	- -	- -	106.28	183.38	79.49	80.99	35.1	28.2	344.14	228.55	60.51	21.97	16.42
EV/Sales High	- -	- -	268.75	308.47	168.49	244.74	99.51	51.89	2,098.79	767.65	165.13	46.92	49.71
EV/Sales Low	- -	- -	1.05	94.02	26.86	32.31	22.53	24.08	22.04	78.89	17.95	5.92	6.55
EV/EBITDA Average	0.36	-17.61	-10.31	-6.2	-3.48	-5.68	-5.1	-14.82	-293.44	-158.5	-20.84	-12.46	-11.48
EV/EBITDA High	0.36	-73.67	-26.07	-10.43	-7.38	-17.17	-14.46	-27.27	-1,789.61	-532.37	-56.87	-26.6	-34.74
EV/EBITDA Low	0.36	-0.91	-0.1	-3.18	-1.18	-2.27	-3.27	-12.66	-18.8	-54.71	-6.18	-3.35	-4.58
EV/EBIT Average	0.36	-17.61	-10.31	-6.2	-3.48	-5.68	-5.1	-14.82	-293.44	-158.5	-20.84	-12.46	-11.48
EV/EBIT High	0.36	-73.67	-26.07	-10.43	-7.38	-17.17	-14.46	-27.27	-1,789.61	-532.37	-56.87	-26.6	-34.74
EV/EBIT Low	0.36	-0.91	-0.1	-3.18	-1.18	-2.27	-3.27	-12.66	-18.8	-54.71	-6.18	-3.35	-4.58
Last Price	- -	120	142.5	93.76	35.18	8.86	0.82	0.22	22.86	4.88	0.9	0.1	0.01
High Price	- -	750	336	164.26	97.14	95.8	10.96	1.43	61.44	26.76	5.48	0.98	0.27
Enterprise Value Average	- -	12	20	18	9	8	4	3	59	54	14	5	4
Enterprise Value High	- -	52	52	31	19	24	11	6	359	181	39	11	12
Enterprise Value Low	- -	1	- -	9	3	3	2	3	4	19	4	1	2

Shares Outstanding	- -	- -	- -	- -	- -	- -	1	2	6	7	7	11	39
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	3	2	4	6	7	11	24
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	3	2	4	6	7	11	24
Revenue per Share	- -	- -	1.63	0.59	0.58	0.49	0.04	0.06	0.04	0.04	0.03	0.02	0.01
EBITDA per Share	-12.66	-10.24	-16.83	-17.35	-13.32	-7.03	-0.27	-0.11	-0.05	-0.05	-0.1	-0.04	-0.01
Operating Income per Share	-12.66	-10.24	-16.83	-17.35	-13.32	-7.03	-0.27	-0.11	-0.05	-0.05	-0.1	-0.04	-0.01
Basic EPS, GAAP	-14.05	-10.97	-18.8	-20.03	-30.97	-23.25	-0.95	1.45	-1.68	0.36	0.14	-0.06	-0.05
Basic EPS from Cont Ops	-14.05	-10.97	-18.8	-20.03	-30.97	-23.25	-0.95	1.82	-1.68	0.39	0.16	-0.06	-0.05
Diluted EPS, GAAP	-14.05	-10.97	-18.8	-20.03	-30.97	-23.25	-0.95	1.45	-1.68	0.36	0.14	-0.06	-0.05
Diluted EPS from Cont Ops	-14.05	-10.97	-18.8	-20.03	-30.97	-23.25	-0.95	1.82	-1.68	0.39	0.16	-0.06	-0.05
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-11.27	-10.83	-10.14	-9.81	-10.05	-7.78	-0.17	0.01	-0.28	-0.1	-0.02	-0.07	-0.02
Free Cash Flow per Basic Share	-11.27	-10.83	-10.14	-9.81	-10.05	-7.78	-0.17	0.01	-0.28	-0.1	-0.02	-0.07	-0.02
Cash & Equivalents per Share	1.67	- -	0.25	0.13	1.45	0.03	0.01	- -	0.13	0.01	0.02	- -	- -
Book Value per Share	1.67	-1.87	-0.68	-3.22	-28.28	-38.01	-13.68	-3.45	-2.33	-1.21	-0.73	-0.5	-0.16
Tangible Book Value per Share	1.67	-1.87	-0.68	-3.22	-28.28	-38.01	-13.68	-3.45	-2.33	-1.21	-0.73	-0.5	-0.16

Regen BioPharma, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)